Role of Metabolically Active Drugs in the Management of Ischemic Heart Disease

Author： Schofield R.S.   Hill J.A.  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.1, Iss.1, 2001-01, pp. : 23-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Ischemic Heart Disease in Patients with Chronic Kidney Disease

By Mutwali Arif  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 4, 2008-01 ,pp. : 219-231

Adis International

Access to resources Recommend Favorite

Defining the Role of Zofenopril in the Management of Hypertension and Ischemic Heart Disorders

By Ambrosioni Ettore  

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 1, 2007-01 ,pp. : 17-24

Adis International

Access to resources Recommend Favorite

Hypertension and Ischemic Heart Disease in Women

By  

Current Pharmaceutical Design, Vol. 22, Iss. 25, 2016-07 ,pp. : 3885-3892

Bentham Science Publishers

Access to resources Recommend Favorite

Barriers to Risk Stratification Accuracy in Ischemic Heart Disease in Women: The Role of Non-Obstructive Coronary Artery Disease

By  

Current Pharmaceutical Design, Vol. 22, Iss. 25, 2016-07 ,pp. : 3928-3934

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Fibric Acid Derivatives in the Management of Risk Factors for Coronary Heart Disease

By Jean-Pierre Després   Isabelle Lemieux  

Drugs, Vol. 64, Iss. 19, 2004-01 ,pp. : 2177-2198

Adis International

Access to resources Recommend Favorite